Wellcross Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.11 M
- Paid Up Capital ₹ 0.11 M
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -63.28%
- Profit Growth 2623.30%
- Ebitda -86.07%
- Net Worth 78.90%
- Total Assets -46.41%
About Wellcross Pharmaceuticals
Wellcross Pharmaceuticals Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 June 2011 and has a history of 13 years and seven months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.11 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Pinalkumar Patel and Shilpagauri Vyas serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2011PTC066000
-
Company No.
066000
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jun 2011
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Wellcross Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pinalkumar Patel
|
Director | 21-Jun-2011 | Current |
|
Shilpagauri Vyas
|
Director | 21-Jun-2011 | Current |
Financial Performance of Wellcross Pharmaceuticals.
Wellcross Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 63.28% decrease. The company also saw a substantial improvement in profitability, with a 2623.3% increase in profit. The company's net worth Soared by an impressive increase of 78.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellcross Pharmaceuticals?
In 2017, Wellcross Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Moksh Pharmaceuticals Private LimitedPinalkumar Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellcross Pharmaceuticals?
Unlock and access historical data on people associated with Wellcross Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellcross Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellcross Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
